Toronto-Dominion Bank signed back-to-back decade-long carbon removal agreements with Climeworks Solutions and Deep Sky, becoming the first major Canadian bank to commit to long-term CDR procurement at scale. The deals widen a buyer base long dominated by Microsoft and signal that financial services firms are beginning to treat durable carbon removal as a balance-sheet hedge.
Generalist AI closed a $400 million round led by Radical Ventures at a $2 billion valuation, sharpening a divide between hardware-first humanoid makers and intelligence-layer challengers. The deal lands days after Nvidia picked Unitree as the body for its first reference humanoid, signaling that capital is now flowing to whoever owns the robot 'brain.'
Hims & Hers closed its $1.15 billion acquisition of Australia's Eucalyptus on June 2, adding more than 850,000 international customers and four new markets. Days earlier, care-navigation startup Garner Health locked in a $2.74 billion valuation, underscoring how digital health capital is concentrating around scaled platforms.
Circle and Nium have linked USDC settlement with Nium's payout rails across 190+ countries, extending stablecoins from a settlement instrument into a full cross-border payments flow. The deal lands as Circle pushes its Agent Stack for AI-driven commerce and rivals from Airwallex to Visa rewire infrastructure for machine-to-machine payments.
Garner Health closed a $100 million Series E led by Index Ventures at a $2.74 billion valuation on May 28, capping a $218 million two-round sprint. The deal underscores how AI-driven provider quality scoring has become the most fundable category in employer health tech.
Anthropic has expanded Project Glasswing from 50 to 200 partner organisations spanning 15 countries, as Claude Mythos Preview surfaces more than 10,000 high-severity vulnerabilities in critical infrastructure codebases across power, water, healthcare and communications sectors.
The European Commission's four-week consultation on simplified ESRS sustainability reporting standards closed June 3, with the executive aiming to adopt the delegated act within weeks. The redrafted standards cut mandatory data points by more than 60% and reporting costs by over 30% per company — reshaping ESG software budgets and capital flows as Europe pulls in $10.5 billion at BlackRock while U.S. sustainable funds shed money for a 14th straight quarter.
JPMorgan, Citigroup, Bank of America and Wells Fargo are building a shared tokenized deposit network through The Clearing House, targeting a first-half 2027 launch. The move is a direct competitive strike at stablecoin issuers Circle and Tether, just as Visa, Ripple and FIS race to ship parallel rails.
Mastercard opened its global card-settlement network to six regulated stablecoins across eight blockchains on June 3, days after Paxos won SEC approval to clear U.S. equities on-chain. The twin moves push stablecoins and tokenized securities from pilot into regulated U.S. financial plumbing — just as Treasury's GENIUS Act AML rules near their June 9 comment deadline.
Mike Schroepfer's Gigascale Capital closed a $250 million debut institutional fund on June 1, doubling down on climate tech as U.S. clean-energy investment contracts for a second straight quarter. The raise lands as carbon removal posts a record Q1 and capital concentrates among proven players.
Healthcare technology spending is shifting from experimentation to core infrastructure as enterprises navigate regulatory pressure, AI integration, and interoperability mandates. This analysis examines the strategic frameworks shaping CIO decisions across hospital systems, payers, and life sciences organizations.
CoStar Group will pay $800 million in cash for Zonda, snapping up NewHomeSource, Livabl and a 3,000-customer homebuilder data franchise. The deal lands as Andy Florance fends off activists, spars with Zillow over Matterport tours, and squares up against an Opendoor turnaround under new CEO Kaz Nejatian.
Blue Origin's May 28 New Glenn explosion destroyed the rocket and gutted Cape Canaveral's LC-36, the company's only orbital launch pad. The fallout is pushing AST SpaceMobile commercial service into 2027, stalling Amazon's Leo build-out and threatening NASA's Moon Base timeline.
AT&T, T-Mobile and Verizon agreed in principle to pool spectrum into a satellite direct-to-device joint venture aimed at killing U.S. dead zones. The rare truce among the Big Three reshapes the competitive map ahead of SpaceX's IPO and forces every satellite operator to integrate through one unified platform.
Apple has pushed its first consumer smart glasses, codenamed N50, from late 2026 into late 2027, according to Bloomberg's Mark Gurman. The delay hands Meta — which already controls more than 70% of the global smart glasses market — another full holiday cycle before Cupertino's iPhone-tethered rival arrives.
The U.S. Department of Justice extracted seven-year commitments from Bayer CropScience to drop tying provisions in its Premier Performance Program for corn and soybean seeds. The move reopens contested ground for independent seed companies and signals that Trump-era antitrust enforcers will pursue agricultural input concentration as a top priority.
Illumina, Guardant Health, and Natera are racing to define the clinical standard for molecular residual disease testing. A platform-by-platform analysis of their technology, FDA status, clinical evidence, and market position as ASCO 2026 reshapes liquid biopsy investment theses.
Illumina opened early access on May 28 to the first distributed whole-genome sequencing kit for molecular residual disease research, pushing ctDNA monitoring out of centralized labs. The launch lands as Roche, Abbott, Myriad and Personalis escalate competing WGS-based MRD bets at ASCO 2026.
The global commercial aircraft backlog hit an all-time high of 16,683 jets in April 2026, representing 12 years of production at current rates. The figures arrive as Boeing wins FAA clearance for rate-47 on the 737 MAX and Airbus pushes back its A320 ramp on engine shortages.
Gilead Sciences won U.S. accelerated approval for Hepcludex on May 22, ending decades without a sanctioned therapy for chronic hepatitis delta virus. The decision lands inside a broader pharma M&A and approval surge — from Eli Lilly's Engage Bio buyout to UCB's $2.2 billion Candid deal — as Big Pharma scrambles to plug pipeline holes ahead of patent cliffs.
Boston Consulting Group and FT Partners' Global Fintech Report 2026 found the sector generated $504 billion in revenue and grew four times faster than incumbent banks. With 74% of major listed fintechs now profitable and $58 billion in fresh equity funding, the industry has exited its reset years as a distinct, mature pillar of financial services.
Oura debuted its Ring 5 on May 28 with cuffless blood pressure monitoring, exploiting an FDA wellness carve-out finalized in January. The launch — alongside Samsung's US rollout and a reported $11 billion IPO filing — marks the first major commercial test of deregulated consumer health tech.
Alphabet priced an upsized $84.75 billion equity capital raise on June 2, anchored by a $10 billion private placement from Berkshire Hathaway. The deal funds a massive AI infrastructure buildout backed by a 2026 capex plan of up to $190 billion. Shares fell on dilution concerns even as Gemini approaches 900 million monthly users.
Defense manufacturer Mach Industries has closed a $300 million Series C at a $1.8 billion valuation, co-led by Infinite Capital and Ribbit Capital. The round nearly quadruples the three-year-old startup's valuation in a year and arrives as the Pentagon ramps drone procurement and venture capital floods autonomous weapons.